Somerset Emsam Gets Committee Review To Evaluate Dietary Restrictions
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's Psychopharmacologic Drugs Advisory Committee to meet Oct. 25-26; the panel will also discuss need for longer-term efficacy data for chronic psychiatric therapies.